Literature DB >> 8110753

The discordant rates of sn-1 aliphatic chain and polar head group incorporation into plasmalogen molecular species demonstrate the fundamental importance of polar head group remodeling in plasmalogen metabolism in rabbit myocardium.

D A Ford1, R W Gross.   

Abstract

Although recent studies have demonstrated the existence of the requisite enzymic machinery necessary for the shuttling of vinyl ether linkages through polar head group remodeling, the relative rates of plasmalogen de novo synthesis and polar head group remodeling are unknown. Pulse-chase radiolabeling of perfused rabbit hearts with [1-3H]hexadecanol demonstrated the rapid and progressive incorporation of radiolabel into plasmenylethanolamine (e.g., after 0.5 h of radiolabeling, 10% of [1-3H]hexadecanol incorporated into ethanolamine glycerophospholipid was in plasmenylethanolamine, and after 1.5 h, 21% was in plasmenylethanolamine) with no detectable radiolabeling of plasmenylcholine until 3 h after the pulse. Furthermore, perfusion of hearts with [1',2'-alkyl-3H2]1-O-alkyl-GPC resulted in the rapid incorporation of radiolabel into plasmanylcholine, but not plasmenylcholine, even after extended perfusion intervals. In contrast, both radiolabeled choline and ethanolamine were rapidly incorporated into plasmalogens through polar head group remodeling at rates that were over 300-fold greater than that of plasmalogen de novo synthesis (e.g., an incorporation rate of 31 nmol/gdry.h for ethanolamine but only 93 pmol/gdry.h for hexadecanol into plasmenylethanolamine was manifest). Similarly, sn-2 remodeling of plasmalogen molecular species with arachidonic or oleic acid also occurred at rates that were over 100-fold greater than that of de novo plasmalogen biosynthesis. Collectively, these results underscore the fundamental importance of rapid polar head group remodeling of plasmalogen molecular species in the synthesis and maintenance of plasmenylcholine and plasmenylethanolamine pools in intact contracting myocardium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110753     DOI: 10.1021/bi00171a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Reflections on the great plasmalogen puzzle: effector mediated signal transduction coupled to glyceride structures.

Authors:  M M Rapport
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 2.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

3.  Intravenously injected [1-14C]arachidonic acid targets phospholipids, and [1-14C]palmitic acid targets neutral lipids in hearts of awake rats.

Authors:  E J Murphy; T A Rosenberger; C B Patrick; S I Rapoport
Journal:  Lipids       Date:  2000-08       Impact factor: 1.880

Review 4.  Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Authors:  Ari Cedars; Christopher M Jenkins; David J Mancuso; Richard W Gross
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

5.  Energy consumption by phospholipid metabolism in mammalian brain.

Authors:  A D Purdon; T A Rosenberger; H U Shetty; S I Rapoport
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

6.  Incorporation of polyunsaturated fatty acids into CT-26, a transplantable murine colonic adenocarcinoma.

Authors:  D P Gaposchkin; R A Zoeller; S A Broitman
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

Review 7.  Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift.

Authors:  Fabian Dorninger; Ernst R Werner; Johannes Berger; Katrin Watschinger
Journal:  Front Cell Dev Biol       Date:  2022-08-31

8.  The ether lipid precursor hexadecylglycerol causes major changes in the lipidome of HEp-2 cells.

Authors:  Jonas Bergan; Tore Skotland; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.